Download the article in PDF format *** On July 21, 2022, the United Kingdom’s Competition and Markets Authority (CMA) fined pharmaceutical companies Pfizer Inc. and Flynn Pharma Limited £63 million and £6 million respectively. The fines levied against these companies are the result of them abusing their market position as a means to overcharge the … Continue reading Pfizer/Flynn medicine monopoly and the NHS: A corporate exploitation of public resources in the United Kingdom
Download the article in PDF format *** There has been a difficulty in bringing to justice corporations which have their subsidiary’s commit breaches of the law. For many years, there was no practical possibility to make multinational corporations accountable for the illicit conducts perpetrated abroad by their subsidiaries. This stems from the existence of the … Continue reading The Nevsun case and the piercing of the corporate veil: A Canadian Revolution?
In recent times, it has emerged that corporations are increasingly using ordinary legal instruments to hush human rights and environmental defenders. Such a phenomenon, which is known as "Strategic Lawsuit Against Public Participation (SLAPP)," is based on the extreme asymmetry in the balance of forces between corporations and activists. The misuse of legal actions to … Continue reading The Ontario anti-SLAPP legislation and the right to free and open expression on matters of public interest